RCPA advises against COVID-19 IgG/IgM rapid tests for the detection of early COVID disease
The RCPA has issued a position statement regarding the serology and point of Care (POCT)Antigen, IgM/A and or G tests which have recently been released into the market in Australia.
We speak with Dr Lyn Waring, Chair of the Royal College of Pathologists of Australasia’s (RCPA) Microbiology Advisory Committee and has been integrally involved in the pathology testing for COVID-19 in Australia.
Australia has the highest rates of diagnostic pathology testing for COVID-19
Australia has delivered the highest rate of pathology testing for COVID-19 of any country in the world per 100,000 population, with over 290,000 tests completed across Australia so far.
We look at the official Government advice which includes the necessary precautions required to protect all individuals, including those who are particularly vulnerable to the virus.
Microbiologist and Infectious Disease specialist, Dr Rohan Beresford discusses how things have changed in his laboratory since the start of the outbreak.
